- Home
- ELVA vs CDTX Comparison
ELVA vs CDTX Comparison
Compare ELVA & CDTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELVA
- CDTX
- Stock Information
- Founded
- ELVA 1996
- CDTX 2012
- Country
- ELVA Canada
- CDTX United States
- Employees
- ELVA N/A
- CDTX N/A
- Industry
- ELVA
- CDTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ELVA
- CDTX Health Care
- Exchange
- ELVA Nasdaq
- CDTX Nasdaq
- Market Cap
- ELVA 71.0M
- CDTX 79.3M
- IPO Year
- ELVA N/A
- CDTX 2015
- Fundamental
- Price
- ELVA $2.31
- CDTX $14.37
- Analyst Decision
- ELVA Strong Buy
- CDTX Strong Buy
- Analyst Count
- ELVA 4
- CDTX 5
- Target Price
- ELVA $8.75
- CDTX $30.50
- AVG Volume (30 Days)
- ELVA 32.7K
- CDTX 21.1K
- Earning Date
- ELVA 12-31-2024
- CDTX 11-07-2024
- Dividend Yield
- ELVA N/A
- CDTX N/A
- EPS Growth
- ELVA N/A
- CDTX N/A
- EPS
- ELVA 0.02
- CDTX N/A
- Revenue
- ELVA $49,490,000.00
- CDTX $44,653,000.00
- Revenue This Year
- ELVA $4.36
- CDTX N/A
- Revenue Next Year
- ELVA $80.25
- CDTX N/A
- P/E Ratio
- ELVA $133.94
- CDTX N/A
- Revenue Growth
- ELVA 45.33
- CDTX 19.60
- 52 Week Low
- ELVA $1.67
- CDTX $10.00
- 52 Week High
- ELVA $4.58
- CDTX $24.40
- Technical
- Relative Strength Index (RSI)
- ELVA 57.26
- CDTX 72.85
- Support Level
- ELVA $2.06
- CDTX $12.89
- Resistance Level
- ELVA $2.74
- CDTX $13.78
- Average True Range (ATR)
- ELVA 0.21
- CDTX 0.70
- MACD
- ELVA 0.02
- CDTX 0.13
- Stochastic Oscillator
- ELVA 57.43
- CDTX 75.31
About ELVA Electrovaya Inc.
Electrovaya Inc designs develop and manufacture proprietary lithium-ion batteries, battery systems, and battery-related products for energy storage, clean electric transportation and other specialized applications. It is a technology-focused company with extensive IP. The company generates revenue from the sale of batteries and battery systems. Business operations are segmented based on large format batteries and others. This technology offers enhanced safety and industry leading battery longevity. Geographically it earns key revenue from the United States.
About CDTX Cidara Therapeutics Inc.
Cidara Therapeutics Inc is developing immunotherapeutics designed to help improve the standard of care for patients facing serious diseases. The Company's portfolio comprises new approaches aimed at transforming existing treatment and prevention paradigms, including DFCs from its proprietary Cloudbreak platform targeting oncologic, viral and autoimmune diseases.